Davenport C, Arevalo-Rodriguez I, Mateos-Haro M, Berhane S, Dinnes J, Spijker R
Cochrane Database Syst Rev. 2024; 12:CD014780.
PMID: 39679851
PMC: 11648846.
DOI: 10.1002/14651858.CD014780.
Nahar K, Begum M, Tony S, Jubair M, Hossain M, Karim Y
Health Sci Rep. 2023; 6(4):e1213.
PMID: 37077182
PMC: 10106929.
DOI: 10.1002/hsr2.1213.
Gadkar V, Goldfarb D, Al-Rawahi G, Srigley J, Smailus D, Coope R
Sci Rep. 2023; 13(1):4241.
PMID: 36918604
PMC: 10013237.
DOI: 10.1038/s41598-023-30993-2.
Tahir B, Weldegebreal F, Ayele F, Ayana D
PLoS One. 2023; 18(3):e0282976.
PMID: 36913377
PMC: 10010556.
DOI: 10.1371/journal.pone.0282976.
Bangalee A, Govender K, Bangalee V
S Afr Fam Pract (2004). 2022; 64(1):e1-e4.
PMID: 36226952
PMC: 9559189.
DOI: 10.4102/safp.v64i1.5492.
Saliva as an alternative specimen to nasopharyngeal swabs for COVID-19 diagnosis: Review.
McPhillips L, MacSharry J
Access Microbiol. 2022; 4(5):acmi000366.
PMID: 36003360
PMC: 9394527.
DOI: 10.1099/acmi.0.000366.
Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in adults is uncommon using rigorous symptom characterization and follow-up in an acute-care adult hospital outbreak.
OGrady H, Dixit D, Khawaja Z, Snedeker K, Ellison J, Erebor J
Infect Control Hosp Epidemiol. 2022; 44(7):1193-1195.
PMID: 35796198
PMC: 9509791.
DOI: 10.1017/ice.2022.168.
Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples.
Lin Y, Malott R, Ward L, Kiplagat L, Pabbaraju K, Gill K
Sci Rep. 2022; 12(1):5418.
PMID: 35354854
PMC: 8967087.
DOI: 10.1038/s41598-022-09218-5.
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2.
Fragkou P, De Angelis G, Menchinelli G, Can F, Garcia F, Morfin-Sherpa F
Clin Microbiol Infect. 2022; 28(6):812-822.
PMID: 35218978
PMC: 8863949.
DOI: 10.1016/j.cmi.2022.02.011.
Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton C, Huntley K, Berenger B, Bristow M, Evans D, Fonseca K
Antimicrob Resist Infect Control. 2022; 11(1):28.
PMID: 35123573
PMC: 8817557.
DOI: 10.1186/s13756-022-01067-1.
Saliva-based COVID-19 detection: A rapid antigen test of SARS-CoV-2 nucleocapsid protein using an electrical-double-layer gated field-effect transistor-based biosensing system.
Chen P, Huang C, Wu C, Chen P, Tripathi A, Wang Y
Sens Actuators B Chem. 2022; 357:131415.
PMID: 35043033
PMC: 8758198.
DOI: 10.1016/j.snb.2022.131415.
Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2.
Berenger B, Fonseca K, Schneider A, Hu J, Zelyas N
Diagn Microbiol Infect Dis. 2022; 102(4):115618.
PMID: 35007959
PMC: 8675123.
DOI: 10.1016/j.diagmicrobio.2021.115618.
Feasibility and Diagnostic Accuracy of Saliva-Based SARS-CoV-2 Screening in Educational Settings and Children Aged <12 Years.
Hoch M, Vogel S, Eberle U, Kolberg L, Gruenthaler V, Fingerle V
Diagnostics (Basel). 2021; 11(10).
PMID: 34679495
PMC: 8534592.
DOI: 10.3390/diagnostics11101797.
Sensitivity of Rapid Antigen Testing and RT-PCR Performed on Nasopharyngeal Swabs versus Saliva Samples in COVID-19 Hospitalized Patients: Results of a Prospective Comparative Trial (RESTART).
Kritikos A, Caruana G, Brouillet R, Miroz J, Abed-Maillard S, Stieger G
Microorganisms. 2021; 9(9).
PMID: 34576805
PMC: 8464722.
DOI: 10.3390/microorganisms9091910.
Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs.
Audige A, Boni J, Schreiber P, Scheier T, Buonomano R, Rudiger A
Microorganisms. 2021; 9(8).
PMID: 34442779
PMC: 8401978.
DOI: 10.3390/microorganisms9081700.
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study.
Migueres M, Vellas C, Abravanel F, Da Silva I, Dimeglio C, Ferrer V
Diagn Microbiol Infect Dis. 2021; 101(3):115478.
PMID: 34364098
PMC: 8279932.
DOI: 10.1016/j.diagmicrobio.2021.115478.
Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants.
de Puig H, Lee R, Najjar D, Tan X, Soeknsen L, Angenent-Mari N
Sci Adv. 2021; 7(32).
PMID: 34362739
PMC: 8346217.
DOI: 10.1126/sciadv.abh2944.
Performance of saliva as a specimen to detect SARS-CoV-2.
Fernandes P, Ferreira F, Morais O, Ramos C, Fernandes E, Rocha S
J Clin Virol. 2021; 142:104913.
PMID: 34304090
PMC: 8285219.
DOI: 10.1016/j.jcv.2021.104913.
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening.
Alkhateeb K, Cahill M, Ross A, Arnold F, Snyder J
Diagn Microbiol Infect Dis. 2021; 101(3):115450.
PMID: 34284319
PMC: 8180088.
DOI: 10.1016/j.diagmicrobio.2021.115450.
A rapid near-patient detection system for SARS-CoV-2 using saliva.
Toppings N, Mohon A, Lee Y, Kumar H, Lee D, Kapoor R
Sci Rep. 2021; 11(1):13378.
PMID: 34183720
PMC: 8238998.
DOI: 10.1038/s41598-021-92677-z.
